These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 3282480

  • 1. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 2. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC.
    J Affect Disord; 1989 May; 16(1):49-58. PubMed ID: 2521651
    [Abstract] [Full Text] [Related]

  • 3. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE, Kraus M.
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [Abstract] [Full Text] [Related]

  • 4. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

  • 5. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Feb; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 6. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Feb; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 8. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks.
    Mavissakalian M, Perel J, Bowler K, Dealy R.
    Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792
    [Abstract] [Full Text] [Related]

  • 9. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL.
    J Psychiatr Res; 1990 Jun; 24 Suppl 2():27-41. PubMed ID: 1980697
    [Abstract] [Full Text] [Related]

  • 10. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R, Anderson DJ, Clancy J, Crowe RR, Slymen DJ, Ghoneim MM, Hinrichs JV.
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [Abstract] [Full Text] [Related]

  • 11. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J, Vallejo J.
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [Abstract] [Full Text] [Related]

  • 13. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE.
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract] [Full Text] [Related]

  • 14. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR, Perel JM.
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [Abstract] [Full Text] [Related]

  • 15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP.
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [Abstract] [Full Text] [Related]

  • 16. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
    Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobeña A, Tyrer P.
    Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772
    [No Abstract] [Full Text] [Related]

  • 17. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS, Woods SW.
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [Abstract] [Full Text] [Related]

  • 18. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 Nov; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 19. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W, Noyes R.
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [Abstract] [Full Text] [Related]

  • 20. Major depression in patients with agoraphobia and panic disorder.
    Breier A, Charney DS, Heninger GR.
    Arch Gen Psychiatry; 1984 Dec; 41(12):1129-35. PubMed ID: 6508503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.